Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Likely reason for presentation pulled

<< Previous

Bullboard Posts

Next >>

Post by Redbaron2211on Apr 23, 2021 12:51am

337 Views

Post# 33053523

Likely reason for presentation pulled

Been busy and havent had a chance to speak to managment but from another trusted source.

"Sernova's surgical team worked with the UBC team on preclinical experiments. The rules for submitting the abstract were that it can't have any company scientists involved in order to keep things more "academic" and legit so to speak. That is why Sam decided to pull the abstract and do a corporate presentation instead."

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?